Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K9WP
|
|||
| Former ID |
DIB009102
|
|||
| Drug Name |
131I-TM-601
|
|||
| Synonyms |
Glioma therapy, Transmolecular; Solid tumor imaging, TransMolecular; TM-602; TM-603; TM-803; Toxin-based anticancers, Transmolecular; Iodine-131-TM-601
Click to Show/Hide
|
|||
| Indication | Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 2 | [1] | |
| Company |
TransMolecular Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Chloride channel unspecific (ClC) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00114309) 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma. U.S. National Institutes of Health. | |||
| REF 2 | Imaging glioma extent with 131I-TM-601. J Nucl Med. 2005 Apr;46(4):580-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.